Open for bids Tender Germany ICB TOT Ref. 152580841

Conclusion of a Non-Exclusive Discount Agreement Tender - 152580841

Tender notice from Germany, published on 17 Nov 2026.

Executive Summary

Title/Summary: Tender for a non-exclusive discount agreement for the active ingredient Sevelamer hydrochloride (ATC V03AE02) issued by DAK-Gesundheit in Hamburg, Germany. The contract period is from January 1, 2027, to December 31, 2028, with an option for a 12-month extension.

Scope Of Work: The tender involves establishing a framework discount agreement under § 130a Abs. 8 SGB V for Sevelamer hydrochloride. The DAK-Gesundheit aims to enter into discount agreements with pharmaceutical companies for the specified active ingredient, with contracts commencing on January 1, 2027, and concluding on December 31, 2028, with a potential extension. Interested bidders must submit required documents, including a letter of offer and acceptance of contractual terms, by email to DAK-Gesundheit by the 5th of the month prior to the desired contract start date.

Qualification Criterion: Bidders must provide a letter of offer, acceptance of DAK-Gesundheit's contractual terms (including specified discounts), and complete Annexes 1 and 2 of the contract. These documents must be submitted via email to DAK-Gesundheit's designated department. Bidders can join the contract at any time during its duration, provided they meet the submission deadlines.

Key facts

Summary
Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Sevelamer Hydrochloride, Atc V03ae02 for the Period January 1St, 2027 - December 31St, 2028 (Plus V. Option 1X12 Months)
TOT Ref. No.
152580841
Document Ref. No.
Login to see
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
17 Nov 2026
Bid deadline
05 Nov 2029
EMD
Refer Document
Tender value
EUR 1.00
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Tender details are for registered users

Login to see details

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The last date to submit a bid for Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Sevelamer Hydrochloride, Atc V03ae02 for the Period January 1St, 2027 - December 31St, 2028 (Plus V. Option 1X12 Months) is 05 Nov 2029. Submit before this date to be considered.

This tender has been issued by DAK HEALTH in Germany.

The estimated tender value is EUR 1.00. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 152580841. The purchaser document reference is available after login.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Materials and Products, Technology and Equipment in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.